HeartSciences Inc. (HSCS)

Market Closed

12 Dec, 20:00

NASDAQ (CM)

2. 58

-0.04

-1.53%

5.99M Market Cap

- P/E Ratio

0% Div Yield

17,829 Volume

-0.2 Eps

$ 2.62

Previous Close

Day Range

2.55 2.74

Year Range

2.01 6.47

Want to track HSCS and more in your Portfolio? 🎯

Get Started For Free

Earnings results expected in 1 days

Summary

HSCS closed yesterday lower at $2.58, a decrease of 1.53% from Thursday's close, completing a monthly decrease of -4.09% or $0.11. Over the past 12 months, HSCS stock lost -32.46%.

HSCS is not paying dividends to its shareholders.

The last earnings report, released on Sep 11, 2025, exceeded the consensus estimates by 2.41%. On average, the company has surpassed earnings expectations by 1.55%, based on the last three reports. The next scheduled earnings report is due on Dec 15, 2025.

HeartSciences Inc. has completed 1 stock splits, with the recent split occurring on May 17, 2024.

The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

Overview
Earnings
Splits

HSCS Chart

Similar

CTSO

Cytosorbents Corporation

$ 0.65

-8.87%

ALVR

Kalaris Therapeutics, Inc.

$ 9.81

+4.14%

CUE

Cue Biopharma Inc.

$ 0.48

-2.27%

MDAI

Spectral AI Inc.

$ 1.6

-6.69%

ICCM

IceCure Medical Ltd.

$ 0.67

-3.5%

HeartSciences Inc. (HSCS) FAQ

What is the stock price today?

The current price is $2.58.

On which exchange is it traded?

HeartSciences Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is HSCS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 5.99M.

When is the next earnings date?

The next earnings report will release on Dec 15, 2025.

Has HeartSciences Inc. ever had a stock split?

HeartSciences Inc. had 1 splits and the recent split was on May 17, 2024.

HeartSciences Inc. Profile

Health Care Equipment & Supplies Industry	Healthcare Sector	Andrew Simpson CEO	NASDAQ (CM) Exchange	42254E104 CUSIP
US Country	15 Employees	- Last Dividend	17 May 2024 Last Split	15 Jun 2022 IPO Date

Overview

Heart Test Laboratories, Inc. is a pioneering medical technology company focused on the innovation of cardiovascular diagnostic devices. Since its incorporation in 2007, the company has dedicated itself to improving cardiac care through advanced technology. Based in Southlake, Texas, Heart Test Laboratories, Inc. primarily caters to a broad array of healthcare facilities including clinics, doctor's offices, urgent care centers, and hospitals. Utilizing cutting-edge technology, the company aims to enhance the diagnostic process for cardiac dysfunction, making it faster, more accurate, and accessible to a wider patient demographic.

Products and Services

MyoVista wavECG

The flagship product of Heart Test Laboratories, Inc., MyoVista wavECG, revolutionizes cardiac diagnostics by offering a resting 12-lead electrocardiograph (ECG) system. This innovative device not only provides the conventional ECG information necessary for detecting a range of cardiac conditions but also integrates advanced diagnostics to identify cardiac dysfunction at its early stages. This dual-capability ensures comprehensive cardiac analysis in a single, non-invasive test, making it an indispensable tool in various healthcare settings from clinics to hospitals.

Contact Information

Address: 550 Reserve Street

Phone: 682 237 7781

Website: https://heartsciences.com

Affiliate Program About Terms Privacy Help Contact Us